The MDG Boston Nominating Committee is Pleased to Present the Following Candidates for the

Board of Directors for a Two-Year Term Starting July 1, 2022

Members in good standing will receive an email with voting instructions.
If you did not receive the email or would like to become a member so you can participate in the elections, please contact us.


1. Candidates for President

Responsible for the overall direction and running of the organization

Jeff Karg, MSME (Incumbent)  -  Managing Director, Boston Innovation

Jeff Karg, MSME (Incumbent) - Managing Director, Boston Innovation

Jeff Karg has served as MDG Boston President and Board Member since July 2020.  Joining in 2012, Jeff focused on programming and worked with Geoff Moodie organizing Forums and other events.

When COVID hit over two years ago, he became president and together with a new Board of Directors led MDG Boston through the changes needed to thrive.  The team put a plan of action together to address the need for change.  And we have been quite successful.

The team:
·      Moved to online programming with professional production.
·      Rebranded with a new logo and community driven website.
·      Implemented community services such as professional mentoring and jobs page.
·      Rewrote the MDG Boston Articles of Incorporation and Bylaws to support its next stage of growth.
·      Implemented a forward thinking Operating Principles formalizing their commitment to diversity and continuous improvement.

All of this designed to support MDG Boston’s mandate as a community of people and members.

MDG Boston is now in year three of a five year plan. This coming two years, with an amazing new board of directors, we will continue to grow our community, build relationships, and make a difference in the state of healthcare one connection at a time.

2. Candidates for Treasurer

Manages financial aspects of the organization

Eric Walters, CPA (Incumbent)  -  CEO, CoFounder & Director, ONEighty C Technologies Corp

Eric Walters, CPA (Incumbent) - CEO, CoFounder & Director, ONEighty C Technologies Corp

Eric Walters currently serves as Treasurer and a Board Member of MDG Boston since July 2018.  During his tenure at MDG, he has managed the financial resources of MDG.  He provides keen insight into strategic planning, business development, product advancement, organizational infrastructure and governance initiatives.

He is a Certified Public Accountant (CPA) with broad experience leading all aspects of the financial landscape including planning, analysis, budgeting, Big Four audit, capital efficiency, internal controls, and cash and treasury management.

He has a comprehensive background in mergers & acquisitions, divestitures, private fund raisings, venture capital, IPOs and SEC filings. He helped drive the growth of a $1M start-up (PolyMedica) to a successful $350M publicly held company, which was later sold in 2007 for approximately $1.5B in cash when revenues were $675M. Sale price per share was 8x IPO share price.

He has been a senior financial executive in both private and publicly-held medical device and health care companies for more than 20 years. He has raised more than $100M in capital and managed Wall Street investor relations for a publicly-held corporation with a $1B market capitalization.

He is a co-founder of the New England Healthcare Executives Network (NEHEN).

Currently, Mr. Walters is CEO, Director and a Co-Founder of ONEighty C Technologies Corporation.  The Company owns WAVEPulse Sterilization TM, a proprietary and first-to-market high-performance sterilization process targeting deficiencies with existing high level disinfection systems in hospitals and other medical institutions which do not adequately sterilize reusable medical devices.

3. Candidates for Secretary (choose one)

Spearheads formal communications for internal meetings and proceedings

Sujit Tatke, MS MBA  -  Program Manager, Smith & Nephew

Sujit Tatke, MS MBA - Program Manager, Smith & Nephew

I am a member of MDG Boston and want to continue to help build its community.  For the last several years, I have participated in Forums and now more recently, partnering with Mr. Karg to help launch the MDG Boston mentoring page.  We have already started seeing initial benefits with participants from different corners of the world reaching out.  I would love to continue and improve this offering.

I have been part of the Medical Device industry for over 15 years and have been looking for meaningful volunteer opportunities within MedTech.  Having a formal role with MDG Boston will allow me to contribute to MDGs mission of serving and nurturing the MedTech ecosystem.  As MDG puts on more high impact events, having a position on the board will allow me to participate in discussions with decision makers and allow me to best use my experience and expertise to enhance our program offerings.

Finally, I am confident that my experience as a Program Manager with Smith & Nephew and Boston Scientific has prepared me for the requirements of the Secretary role.  My day-to-day work involves managing internal and external stakeholders.  Communicating up, down and across the organization through formal and informal channels is a key element of my job.  Over the years, I have gotten better at it and I hope to utilize these skills on the MDG Boston Board of Directors.

Tina Guanting Qiu, MD, PhD  -  Consulting Chief Medical Office, Ophthalmic Therapeutic Innovation

Tina Guanting Qiu, MD, PhD - Consulting Chief Medical Office, Ophthalmic Therapeutic Innovation

Dr. Qiu is an accomplished biopharma executive consultant with 25 year US and international experience in leading some of the most exciting ophthalmic therapeutic innovations: stem cell & gene therapy, drug discovery & delivery, and combination product development. Recently she served as Consulting Chief Scientific & Medical Officer for Lineage Cell Therapeutics, helping remove the key stumbling blocks and creating product values for the OpRegen hRPE line, which contributed to the $670M deal with Roche/Genentech. She pioneered the use of 41G minimally invasive subretinal gene delivery, which became the standard of care today. She helped Inotek Pharma to rebuild multi-million $ R&D pipelines at zero cost and contributed to the IPO success. During the COVID19 spring surge in 2020, she spearheaded the UK-US strategic task force consortium for global therapeutic development, saving countless lives. As an expert of ocular drug delivery, she helped clients design top tier product lines capturing a $20B market cap with unmatched speed and quality. She started her career at GSK, where she built the first Ophthalmology business unit. As a trusted medical advisor, she excelled at Astellas Pharma, Sanofi, Regeneron, LambdaVision and Ocular Therapeutics.

She has a Medical Doctor degree (with honors) from Nanchang University, a Doctorate of Ophthalmology from National Sun Yat-sen University in collaboration with Sheie Eye Institute/UPENN on a PhD thesis project in stem cell transplant, followed by post-doctoral trainings at Boston University and University of Southern California. She was a board certified Ophthalmologist in China; an elected member of American Academy of Ophthalmology.

4. Candidates for Member Advocate (choose one)

–   Serves as the primary Member advocate providing an integral communications link between Members and the Board

–   Obtains Member feedback relative to the organization’s value proposition

Mark Wladkowski, MS MBA  -  Senior VP, R&D, Smith & Nephew

Mark Wladkowski, MS MBA - Senior VP, R&D, Smith & Nephew

Across my career in the medical device space, I have had the opportunity to lead R&D and engineering, portfolio management, operations, regulatory affairs, and program management for Zimmer Biomet, Medtronic, and Smith & Nephew. My work has included building global talent, empowering teams, and turning stagnant operations into revenue-generators.

I am running for the MEMBER ADVOCATE as the mission of MDG Boston aligns well with what my interests are:

·       Promoting the Medical Device Ecosystem in Massachusetts

·       Continuing to develop products that positively improve the lives of patients

·       Improve the funnel of top talent to choose a career as a medical device innovator

In addition, I am the chairman of the board at UMass Lowell Biomedical Engineering Industrial Advisory Board and developing talent and unlocking opportunity is important to me.

Rodan Zadeh, MBA  -  Senior Director, Digital Health Strategy & Innovations, Cognizant

Rodan Zadeh, MBA - Senior Director, Digital Health Strategy & Innovations, Cognizant

Driven by mission to improve and save lives through innovations in health care, I am the Sr. Director of digital health strategy and innovations for Cognizant, a global consulting and services firm.

In this capacity, I am delivering strategic services for health sciences clients, including F100 medical device and pharma clients. Prior to this role, I co-founded Cognizant Accelerator, an internal business incubator, where I developed sustaining business strategies for new ventures.  Outside of Cognizant, I am actively involved in advising several digital health startups, new venture groups and health organizations. These include being a mentor/judge for MassChallenge, owner of LinkedIn Medtech group (11k members), membership in MassBio, and Georgia Tech Health ventures. I am a graduate of MIT, and have a bachelor’s degree in Electrical and Computer Engineering and a Master of Science degree in management.

If fortunate enough to serve on Board of Directors for MDG Boston, I would leverage my network and broad access, to advocate for increased membership and draw awareness to MDG’s mission and goals. Our industry is at cross-roads in combining traditional medical solutions, digital solutions and new business models to deliver tremendous value to patients – at an unprecedented scale. To stay relevant, it is important that MDG be at the forefront of this transformation.  As a believer in value of innovations in our field, with my experience will draw interest for further collaboration, and thus higher visibility to our work.

It would be an honor to be selected to join this group of distinguished individuals to make a difference to our community and to the patients that benefit from it.

5. Candidates for Human Resources

–  Provides leadership in fostering organization structure and values

–  Leads diversity and inclusion initiatives

Glenn Wambolt, BS (Incumbent)  -  Advisory Consultant, Coleman Research

Glenn Wambolt, BS (Incumbent) - Advisory Consultant, Coleman Research

As a progressive, results-oriented Human Resources Executive, I have over 25 years of experience providing thought leadership to CEO’s and senior leadership teams of global organizations within the healthcare, manufacturing, and high-technology/software industries. I am well-versed in all facets of Human Resources including Organizational Effectiveness, Employee Engagement, Change Management, Talent Acquisition, Talent Development, Compensation, Employee Relations, and Labor Relations.

Prior to transitioning to consultancy, my experience includes six years as Vice President Human Resources for Hexagon Manufacturing Intelligence where I reported directly to the CEO and was a key member of Hexagon’s Global Human Resources Leadership Team. Before joining Hexagon, I was with Johnson & Johnson for nearly 20 years in a variety of Sr. Level HR roles across multiple operating companies as well as J&J’s corporate headquarters.

I earned a BS degree in Human Resources Management from the University of Massachusetts and did extensive graduate work in Labor and Industrial Relations at the University of Rhode Island along with the completion of an advanced executive education program at Cornell University.

As a member of the MDG Board this past year, I’ve leveraged my organizational effectiveness skills, assisting the team in putting additional structure in place that will contribute to the achievement of MDG’s vision. I look forward to the prospect of continuing to serve on the board and playing a key role in driving the organization’s growth and continued success.

6. Candidates for Branding and Community Messaging 

–  Establishes and maintains a strategic approach to branding and communication

–  Oversees website development and supports promotional efforts

Ilsa Webeck, MBA (Incumbent) -  Managing Director & Founder, MedTech Strategies

Ilsa Webeck, MBA (Incumbent) - Managing Director & Founder, MedTech Strategies

Ilsa Webeck is a creative healthcare professional with over 20 years of strategy, marketing and product development experience. As the founder of MedTech Strategies, she sits at the nexus of product development and commercialization, working with companies of all sizes to identify product value propositions and actionable outcomes for growth.

Her past roles include corporate planning, product management and early product strategy at HeartWare, Biogen, Johnson & Johnson’s DePuy Spine and Health Advances.

Ilsa holds a BA in Biology from Dartmouth College and an MBA from the Tuck School of Business.  As Course Director for Harvard Catalyst, she directed the TRANSCEND program for startups and entrepreneurs looking to improve their approach to growing their business.  Additionally, she is a judge and mentor for MassChallenge.

For the last 4 years, Ilsa spearheaded several MDG Boston programs which helped the organization weather the pandemic and be positioned for future success.  She lead the development of the new branding, website (with pages such as: expert advice, jobs postings, community connections) and communication approaches, drove the new sponsorship engagement program and spearheaded the strategic planning retreat resulting in organizational alignment for the future.

Ilsa looks forward to two more years on the board, where she can continue to expand on the work done to date (i.e., launch the new member and sponsor portals) and continue to establish MDG Boston as a premier networking and educational organization in the medtech industry.

7. Candidates for Communications and Promotion

–  Leads efforts to ensure events are communicated to the MedTech industry

–  Oversees and executes event promotion through multiple channels

Steve Amato, PhD, MBA - Head of Regulatory Services, Professor and Advisor in Regulatory Affairs, Reimbursement, Pricing and Health Economics, Northeastern University

Steve Amato, PhD, MBA - Head of Regulatory Services, Professor and Advisor in Regulatory Affairs, Reimbursement, Pricing and Health Economics, Northeastern University

MDG’s membership value proposition should include the following:
–  Education & Development – Professional advancement through learning evolving global medical technology trends

–  Networking Opportunities – Provide a setting for membership to expand their professional networks, and to strengthen their collaborations

–  Entrepreneurship – Exposure to innovative ideas, including identification of new market opportunities

These ideas should be embedded the organization’s public facing communications, statements, social media presence, and public relations initiatives.

Who is MDG?  A core belief of MDG membership is that advances in technology often lead to substantial improvements in health care outcomes, efficiency, and costs.  Although based in the Boston area, MDG membership may extend geographically throughout New England, with significant potential to expand globally.  As a hub for healthcare technology Greater Boston affords an excellent location with prominent academic institutions, world-class medical centers, manufacturers, and a wealth of human resource talent.  MDG’s brand, as well as its communication strategies should reflect these core beliefs.

MDG’s Focus:  The focus of MDG should be on the individual – professionals who are engaged in the medical technology industry or are looking to enter.  They are engineers, regulatory and reimbursement specialists, commercialization professionals, quality specialists, attorneys, clinicians, finance professionals, and more.  MDG’s communication focus should reinforce that membership provides life-long opportunities for learning, professional networking, and entrepreneurship in the global medical technology industry.  Over time, this may also include biotechnology, and biopharmaceutical related content in addition to medical device related discussions.

8. Candidates for Growth Strategy (2 positions open – can choose both)

–  Develops a strategic plan for organizational growth and expansion

–  Collaborates across the organization to ensure the achievement of MDG Boston’s vision

Todd Astor, MD -  Founder & CEO, Biomembretics, Medical Director, Lung/Heart-Lung Transplant Center

Todd Astor, MD - Founder & CEO, Biomembretics, Medical Director, Lung/Heart-Lung Transplant Center

As a physician in the pioneering frontier of organ transplantation, I have had the opportunity to take care of and help develop therapies for so many courageous patients.  But as I learned from my early failures, scientific innovation is not enough…capturing that value for patients requires unique skills and expertise from many different stakeholders.  I became committed to expanding my network and searching for creative ways to bridge the gaps between academia, clinical practice, industry, and government.

Several years ago I participated as a panelist in an MDG event, “Delivering Innovation in Critical Care: Advanced Life Saving Pump Technologies”, and presented a physician perspective as seen through strategic, political, and cultural lenses. I was so excited by the depth and enthusiasm of the discussions and feedback…it was a pivotal introduction for me to the vast ecosystem and platform that are the essence of MDG.  The experience helped spark the desire and confidence to launch my own MedTech start-up company.

The limitless Boston ecosystem, unprecedented support for entrepreneurship, and raised level of investor interest, coupled with expansive virtual capabilities born during the pandemic, have created fertile ground from which MDG can grow as a nexus of innovation. But MDG is more than a forum to bring silos together… it is an opportunity to break them down entirely, and help each member redefine his or her own value for advancing innovative therapies for patients. It is with that vision that I seek to join the MDG Board as Director of Growth Strategy.

Shinikequa White, MBA  -  Director, Strategic Planning, Smith & Nephew

Shinikequa White, MBA - Director, Strategic Planning, Smith & Nephew

I believe in MDG Boston’s strategic focus of building community and communicating its identity through unique programming.  In line with MDG Boston’s mission, I believe the next few years should be geared toward enhancing membership experiences, delivering competitive forums with relevant content with diverse representation, and expanding sponsor relationships.

Much of my professional experience in the MedTech industry has been centered on understanding key markets, target customers, and an organization’s value proposition. Through these experiences, I have achieved business successes by building long term strategic direction.  Importantly, I work with the leadership team to build an execution plan with achievable metrics that allows an organization to live into the strategy.

This can be done by building individual relationships that foster mentoring, learning, development, and industry transformation, with MDG shaping a long term, “way of life” in the MedTech industry.  I am confident that I can work with the MDG Boston team to make a lasting impression in this organization as I did at Johnson and Johnson as a part of successful, innovative and hardworking teams.  I would bring that same work ethic to the board.

I often work to build alignment amongst cross functional teams of leaders such that strategy and tactics speak to the culture of the community. I also have long term experiences shaping complex value stories for audiences. I look forward to bringing this approach and skill set to the new board.

9. Candidates for Membership

–  Drives membership growth by implementing the Membership Value Proposition

–  Optimizes positive Member experience 

Loretta McHugh, MBA -  Director of Quality, Henke Sass Wolf of America

Loretta McHugh, MBA - Director of Quality, Henke Sass Wolf of America

She is the Director of Quality at a medium sized medical device company in central Massachusetts. She has been in the Director role for 12 years and was previously a Quality Engineer at the same company for 7 years. She is a long-term member of ASME, SWE, and ASQ.

Loretta has volunteered with the American Society of Mechanical Engineers (ASME) since 1995 at the college, local, and national level. As part of several of her volunteer roles, Loretta has been the Chair of two groups focused on membership growth and retention within ASME: early career engineers and women in engineering. She looks forward to utilizing her experiences from ASME with finding value for membership with MDG Boston in today’s challenging environment. In Loretta’s free time, she likes to train for and run half marathons – #28 is on the calendar for October 2022.

10. Candidates for Programming (choose two)

–  Oversees selection of forum topics

–  Manages volunteers who develop and execute forums

Geoff Moodie, PhD  -  Director, Biocompatibility Eurofins (Incumbent)

Geoff Moodie, PhD - Director, Biocompatibility Eurofins (Incumbent)

I’ve been involved in the medical device industry for over 20 years, working on combination product development and product testing for regulatory submission.  In seeking to become more integrated into a community with a shared passion for new medical technology I became involved with MDG in 2015.

In 2016 I assumed the head of programming and have been in that position up until this time.  In this position I’ve been responsible for directing topic selection, recruiting and formalizing procedures for forum champions, making the changes to our format to accommodate our new virtual platform, and collaborating with the amazing team at MDG to create great forum content.

My goal in being reelected to MDG’s board is to continue the above, but also to expand program offerings to additional networking and educational events.  By this I hope to add even more value to MDG event attendees.

I am also very much excited by our new expanded board and the additional skills, experience, and horsepower it will bring.

For these reasons I am asking for your vote so that I can continue helping MDG to adapt, evolve, and grow for another two years.

Erin Cosgrove, MBA  -  VP, Business Development, RQM+

Erin Cosgrove, MBA - VP, Business Development, RQM+

MDG has a long history of providing high quality programming and I’ve gained new knowledge from many of the sessions.  As the Programming Director, I’d continue to deliver innovative topics based on feedback from both MDG members and non-members of the MedTech community.

We’re in a time of tremendous change for the industry as our global population ages, regulations change, funding enters a more challenging cycle and technology evolves. This is an incredible time to learn from MedTech experts and use that knowledge to drive and adapt to our changing industry. I’d love to be a part of making that happen!

My background includes over 20 years of MedTech commercial leadership, including both medical devices and diagnostics.  I’ve led the program creation of conference keynote and panel sessions as well as industry specific online webinars and other educational content. I’ve developed and grown teams and will work closely with the forum volunteers to plan and deliver an exciting set of forum sessions.

Martin Gomez, JD Attorney  -  Goodwin Procter

Martin Gomez, JD Attorney - Goodwin Procter

I am a Partner in Goodwin Procter’s Boston office and co-leader of its MedTech practice.  I am a corporate lawyer and registered patent attorney and specialize in representing medical device companies of all sizes (including start-ups), and their investors, in corporate and IP matters throughout the business life cycle.  I also lead a sector group focused on the incorporation of artificial intelligence and machine learning technologies into medical products.  Before becoming a lawyer I was a mechanical engineer that designed x-ray systems.

During my career, I’ve worked with businesses across many sectors, but decided several years ago to focus heavily on medical device companies.  I am deeply passionate about technology that can make a difference in patients’ lives – and being a MechE, found devices much more interesting that drugs!  I’m consistently blown away by my client’s ingenuity and brilliance in creating products that have such great impact in the world.  And as a lawyer to many such companies, I get to live the story over and over again, which is a great joy.

I am seeking a position on the MDG Boston board because I genuinely believe my background and connections in the industry can add significant value to the group, and I am very interested in becoming deeper engrained in the Boston MedTech ecosystem.  I am also interested in attending/hosting more in person networking and educational events.

11. Candidates for Sponsor Fulfillment

–  Proactively manages Sponsor relations and benefits

–  Guides Sponsor participation within the MDG Boston community

Judy White, MBA. Director of Marketing, Hamilton, Brook, Smith & Reynolds

Judy White, MBA. Director of Marketing, Hamilton, Brook, Smith & Reynolds

As the Director of Marketing for a Boston-based IP law firm, Hamilton Brook Smith Reynolds, I have thoroughly enjoyed sponsoring MDG Boston, assisting in Forum programming, and providing feedback on the value of sponsoring. My perspectives over the last 6 years on the MDG Boston marketing strategy, combined with the opportunity to develop inter-sponsor relationships, provide an untapped opportunity to educate and lead our community in serving MDG Boston’s mission.

I believe that Sponsor Advocate’s legwork begins with contacting each sponsor directly, gaining feedback, and encouraging them to schedule events and build relationships. Sponsors are looking to give back to the community first and, of course, generate new business.

Key activities for the Sponsor Advocate are to:

a)     help sponsor companies to develop topics that share their knowledge,

b)    solicit sponsor partnerships to create integrated programming, and

c)     reach out to the membership base to gain new speakers.

A key event for the coming year is to get the sponsorship companies together for a social event. Additionally, I am interested in getting Massachusetts-based universities involved with MDG Boston. I am impressed with the thought leadership and community outreach MDG Boston has achieved.

I believe developing long-term personal relationships within the community is vital to MDG Boston’s mission.